Tag Archive | "Watson"

M&A news: Watson aim to acquire Actavis by April

Tags: , , , ,


Watson Pharmaceuticals Inc is on track to announce a M&A deal to buy Actavis for around $6 billion by the end of April, creating one of the world's biggest producers of generic drugs, sources familiar with the matter said on Wednesday Read the full story

Rumours circle of mega mergers

Tags: , ,


In the past few days rumours have emerged that two mega mergers are in the offing Read the full story

Watson close to $7 billion Actavis drug deal

Tags: , , ,


(Reuters) - Watson Pharmaceuticals Inc. is close to buying Swiss-based Actavis for around $7 billion (4 billion pounds), marking the latest deal between generics companies racing to achieve economies of scale, three sources familiar with the matter said.  Read the full story

Watson acquires Ascent Pharmahealth for AU$375 million in cash

Tags: , ,


Watson Pharmaceuticals has acquired Ascent Pharmahealth for AU$375 million in cash.

As a result of the acquisition, Watson becomes the fifth largest generic pharmaceutical company in Australia based on revenue, and the combined company will be the second largest in terms of total molecules.  Read the full story

Watson Chief Executive Bisaro says he’s hunting for ‘larger transaction’

Tags: , , , ,


Watson Pharmaceuticals Inc. (WPI) Chief Executive Officer Paul Bisaro said the company is interested in buying either a generic or brand-name drugmaker.  Read the full story

Amgen and Watson announce collaboration to develop and commercialize oncology biosimilars

Tags: , ,


Amgen and Watson Pharmaceuticals will collaborate to develop and commercialize, on a worldwide basis, several oncology antibody biosimilar medicines.  Read the full story

Watson expands European presence with Specifar acquisition

Tags: , ,


Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million ($562 million) in cash and certain contingent consideration. Read the full story

Watson acquires Specifar Pharma for $562m

Tags: ,


Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million ($562 million) in cash and certain contingent consideration Read the full story

Ortho-McNeil Pharma enters into agreement with Watson Labs for authorised generic

Tags: ,


Ortho-McNeil-Janssen Pharmaceuticals, Inc. has announced it has entered into a supply and distribution agreement with Watson Laboratories, Inc. to distribute an authorized generic version of CONCERTA® (methylphenidate HCl extended-release tablets). Watson will launch the authorized generic beginning May 1, 2011. Read the full story

Watson Pharmaceuticals, Moksha8 Form Marketing Partnership for Brazil, Mexico; Watson Makes Initial $30 Million Investmen

Tags: ,


Agreement that will expand Watson's commercial presence in Latin America's two largest markets, Brazil and Mexico. Watson will invest $30 million in Moksha8 as part of Moksha8's approximately $61 million USD financing that includes investments from existing investors TPG Biotechnology and Montreux Equity Partners. Read the full story